CA
NZ
UK
AU
IND
US
The company said the increase came from higher occupancy and integrated services growth in Canada, plus a stronger Australian dollar. Canadian revenue rose 38% and adjusted EBITDA rose 47%, driven mainly by higher occupancy at oil sands lodges, reflecting stronger-than-expected turnaround activity.
Net operating income reached $179.1 million, or $1.90 per diluted share, compared with $127.2 million, or $1.29, in the prior year quarter.
Net income still climbed to $718.7 million from $432.6 million, equal to $2.51 per diluted share against $1.50.
The company's core net income, a non-GAAP measure, was $40.6 million, or $0.16 per share, versus $15.4 million, or $0.07. Return on average assets was 0.13%, against 0.55%, while core return on average assets rose to 0.97% from 0.56%.
United States sales slipped 1% to $540.9 million, which the company tied to later shipments of Fall 2026 wholesale orders, partly offset by direct-to-consumer growth. Latin America and Asia Pacific rose 11%, Europe, Middle East and Africa rose 7%, and Canada fell 2%.
Net income was $49.8 million, versus $43.7 million a year earlier and $48.6 million in the second quarter. Diluted EPS was $0.41, compared with $0.37 and $0.40. FFO per diluted share was $0.71 in both the third and second quarters, compared with $0.69 a …
Gross profit was $220.1 million, up 108%, and grossMarginwidened to 58.4% from 54.6%. Adjusted EBITDA was $61.5 million, up from $15.6 million, with the margin rising to 16.3% from 8.0%.
Net income available to common stockholders was $17.0 million, or $0.10 per share, against $8.6 million, or $0.05. Total revenues were $259.4 million, up from $248.3 million, which is growth of about 4.5% on a calculated basis.
Net income was $10.7 million versus $9.1 million, and EPS was $0.40 versus $0.35. AdjustedNet Incomewas $13.2 million versus $11.5 million, and adjusted EPS was $0.50 versus $0.44.
Revenue was $511.5 million, up $49.2 million, or 10.7%, from $462.3 million in the prior year period. Chamberlain contributed $192.4 million, up 7.4%, Walden $216.7 million, up 14.1%, and Medical and Veterinary $102.5 million, up 10.0%.
Please wait processing your request...